Literature DB >> 1351264

Hypothalamic-pituitary-adrenal axis function in chronic schizophrenia: association with clinical features.

M Kaneko1, F Yokoyama, Y Hoshino, K Takahagi, S Murata, M Watanabe, H Kumashiro.   

Abstract

The function of the hypothalamic-pituitary-adrenal axis (HPA-axis) and its association with clinical features in chronic schizophrenia were investigated. Twenty of 33 chronic schizophrenics exhibited an abnormal diurnal variation of the saliva cortisol level. The patients with abnormal diurnal variation gave higher scores for some negative symptoms than those with normal diurnal variation. On the dexamethasone suppression test (DST) of saliva samples, 13 of 34 chronic schizophrenics were abnormal. The patients with DST nonsuppression were more frequently classified into disorganized type and exhibited low scores of anxiety compared with the patients with normal suppression. The 9 patients who showed abnormal diurnal variation and DST nonsuppression were more frequently classified into disorganized type and showed higher scores of negative symptoms than the 9 patients who did not show any abnormal cortisol data. These results suggest that there might be some disturbance in the function of the HPA-axis in a group of chronic schizophrenics and that these patients might have severe negative symptoms.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1351264     DOI: 10.1159/000118800

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  7 in total

1.  Stress sensitivity in metastatic breast cancer: analysis of hypothalamic-pituitary-adrenal axis function.

Authors:  David Spiegel; Janine Giese-Davis; C Barr Taylor; Helena Kraemer
Journal:  Psychoneuroendocrinology       Date:  2006-11-01       Impact factor: 4.905

2.  Pituitary volume in schizophrenia spectrum disorders.

Authors:  F Romo-Nava; W S Hoogenboom; P E Pelavin; J L Alvarado; L H Bobrow; F P Macmaster; M Keshavan; R W McCarley; M E Shenton
Journal:  Schizophr Res       Date:  2013-03-19       Impact factor: 4.939

3.  The biochemical womb of schizophrenia: A review.

Authors:  N Gaur; S Gautam; M Gaur; P Sharma; G Dadheech; S Mishra
Journal:  Indian J Clin Biochem       Date:  2008-12-20

4.  Association between Serum Cortisol and DHEA-S Levels and Response to Antipsychotic Treatment in Schizophrenia.

Authors:  Zoja Babinkostova; Branislav Stefanovski; Danijela Janicevic-Ivanovska; Valentina Samardziska
Journal:  Open Access Maced J Med Sci       Date:  2015-02-22

5.  The status of serum cortisol before and after treatment of schizophrenia and its correlation to disease severity and improvement: A longitudinal study.

Authors:  Yohannes Markos Woldesenbet; Arefayne Alenko; Iyasu Tadesse Bukata; Lealem Gedefaw; Chaltu Fikru
Journal:  SAGE Open Med       Date:  2021-11-09

6.  Schizophrenia clinical symptom differences in women vs. men with and without a history of childhood physical abuse.

Authors:  Deanna L Kelly; Laura M Rowland; Kathleen M Patchan; Kelli Sullivan; Amber Earl; Heather Raley; Fang Liu; Stephanie Feldman; Robert P McMahon
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2016-03-03       Impact factor: 3.033

Review 7.  Circadian rhythm disruption and mental health.

Authors:  William H Walker; James C Walton; A Courtney DeVries; Randy J Nelson
Journal:  Transl Psychiatry       Date:  2020-01-23       Impact factor: 6.222

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.